htert expression correlates with MYC over-expression in human prostate cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Basic local alignment search tool
1990 • 87,358 citations
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
1987 • 64,270 citations
Creation of human tumour cells with defined genetic elements
1999 • 2,333 citations
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
1997 • 2,256 citations
Direct activation of TERT transcription by c-MYC
1999 • 871 citations
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
1996 • 787 citations
Myc activates telomerase
1998 • 650 citations
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
1995 • 490 citations
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
1999 • 404 citations
Telomerase activity: a prevalent marker of malignant human prostate tissue.
1996 • 394 citations
Beta-catenin mutations in human prostate cancer.
1998 • 368 citations
BIN1 is a novel MYC–interacting protein with features of a tumour suppressor
1996 • 358 citations
The Histology and Prognosis of Prostatic Cancer
1967 • 264 citations
Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.
1999 • 251 citations
Control of cell proliferation by Myc
1998 • 251 citations
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
1998 • 237 citations
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
1998 • 129 citations
Telomerase Activity in Primary Prostate Cancer
1997 • 118 citations
Commonly occurring loss and mutation of theMXI1 gene in prostate cancer
1998 • 82 citations
Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: A novel therapy in prostate cancer
1997 • 58 citations
p53 and c-myc Expression in Stage A1 Prostatic Adenocarcinoma: Useful Prognostic Determinants?
1993 • 55 citations
Amplification, rearrangement, and elevated expression of c‐myc in the human prostatic carcinoma cell line LNCaP
1989 • 44 citations
Genetic aspects of prostate cancer
1998 • 44 citations
Telomerase and cancer.
1996 • 33 citations
Cited By (0)
No citing papers found in database